We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

168 hedge funds and large institutions have $1.61B invested in NxStage Medical Inc. in 2017 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 39 increasing their positions, 51 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,040% more call options, than puts

Call options by funds: $28.2M | Put options by funds: $2.47M

11% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 55

3% more funds holding

Funds holding: 163168 (+5)

4% more capital invested

Capital invested by funds: $1.55B → $1.61B (+$66.3M)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

24% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 51

Holders
168
Holders Change
+5
Holders Change %
+3.07%
% of All Funds
4.19%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
61
Increased
39
Reduced
51
Closed
55
Calls
$28.2M
Puts
$2.47M
Net Calls
+$25.7M
Net Calls Change
+$23.7M
Name Holding Trade Value Shares
Change
Change in
Stake
TAM
76
Tiverton Asset Management
Delaware
$2.72M -$329K -12,338 -11%
Squarepoint
77
Squarepoint
New York
$2.43M +$2.35M +88,000 New
SCM
78
Sterling Capital Management
North Carolina
$2.26M +$459K +17,193 +27%
Point72 Asset Management
79
Point72 Asset Management
Connecticut
$2.26M -$4.94M -185,152 -69%
RhumbLine Advisers
80
RhumbLine Advisers
Massachusetts
$2.17M +$35.6K +1,335 +2%
OA
81
Outfitter Advisors
Virginia
$2.16M +$6.4K +240 +0.3%
IA
82
IndexIQ Advisors
New York
$2.14M +$2.07M +77,492 New
Parallax Volatility Advisers
83
Parallax Volatility Advisers
California
$2.02M +$1.91M +71,756 +4,402%
CI
84
Cowen Inc
New York
$1.91M +$1.84M +69,100 New
New York State Common Retirement Fund
85
New York State Common Retirement Fund
New York
$1.89M
PG
86
PEAK6 Group
Illinois
$1.87M +$1.8M +67,652 New
Marshall Wace
87
Marshall Wace
United Kingdom
$1.85M +$1.76M +65,940 New
AQR Capital Management
88
AQR Capital Management
Connecticut
$1.74M +$1.11M +41,537 +195%
EAM
89
Exane Asset Management
France
$1.66M +$1.6M +60,000 New
AGM
90
Alpine Global Management
New York
$1.52M +$1.47M +55,186 New
KI
91
Koch Industries
Kansas
$1.52M +$1.23M +45,952 +508%
SMC
92
S. Muoio & Co
New York
$1.38M +$1.33M +50,000 New
CIA
93
Capital Impact Advisors
Massachusetts
$1.38M +$473K +17,729 +55%
Manulife (Manufacturers Life Insurance)
94
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.36M -$31.9K -1,196 -2%
Susquehanna International Group
95
Susquehanna International Group
Pennsylvania
$1.33M -$3.92M -147,013 -75%
PPA
96
Parametric Portfolio Associates
Washington
$1.27M -$403K -15,115 -25%
State Board of Administration of Florida Retirement System
97
State Board of Administration of Florida Retirement System
Florida
$1.24M
MLICM
98
Metropolitan Life Insurance Company (MetLife)
New York
$1.2M
AIG
99
American International Group
New York
$1.2M +$86.8K +3,256 +8%
ERSOT
100
Employees Retirement System of Texas
Texas
$1.19M

NXTM Hedge Fund Activity: Q3 2017 in Review

168 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q3 2017, worth a combined $1.61B — up 4.3% from $1.55B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new NXTM positions and 55 closed out — a net gain of 6 holders — while 39 added to existing stakes and 51 trimmed.

The largest buyer was Alpine Associates Management, opening a new position worth an estimated $106M. The largest seller was Fidelity Investments, cutting an estimated $249M.

  • 168 institutional investors held NxStage Medical Inc. (NXTM) as of Q3 2017, up from 163 in Q2 2017.
  • Funds reported $1.61B of NxStage Medical Inc. stock for Q3 2017, up 4.3% quarter-over-quarter.
  • 61 funds opened new NxStage Medical Inc. positions in Q3 2017 and 55 closed out, a net change of +6 holders.
  • The largest NxStage Medical Inc. buyer in Q3 2017 was Alpine Associates Management, an estimated $106M added.
  • The largest NxStage Medical Inc. seller in Q3 2017 was Fidelity Investments, an estimated $249M sold.

Based on aggregated 13F filings for Q3 2017.